GSE147876,GSE147877 4 V 6 ENZALUTAMIDE HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE147876,GSE147877 4 V 6 ENZALUTAMIDE HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE147876,GSE147877 4 V 6 ENZALUTAMIDE HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE147876,GSE147877 4 V 6 ENZALUTAMIDE HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE147876,GSE147877 4 V 6 ENZALUTAMIDE HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

H4 clustered histone 15

Gene

valyl-tRNA synthetase 1

Gene

ral guanine nucleotide dissociation stimulator like 2

Gene

mitochondrial ribosomal protein S18B

Gene

H3 clustered histone 7

Gene

H3.7 histone (putative)

Gene

mitochondrial elongation factor 1 upstream open reading frame

Gene

CFAP298-TCP10L readthrough

Gene

myosin XVB

Gene

TruB pseudouridine synthase family member 2

  • Gene

    H4 clustered histone 15


  • Gene

    valyl-tRNA synthetase 1


  • Gene

    ral guanine nucleotide dissociation stimulator like 2


  • Gene

    mitochondrial ribosomal protein S18B


  • Gene

    H3 clustered histone 7


  • Gene

    H3.7 histone (putative)


  • Gene

    mitochondrial elongation factor 1 upstream open reading frame


  • Gene

    CFAP298-TCP10L readthrough



  • Gene

    TruB pseudouridine synthase family member 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.